Health Affairs, 25, no. 5 (2006): 1260-1269 doi: 10.1377/hlthaff.25.5.1260 © 2006 by Project HOPE	New Online   Pay Cuts For Medicare Docs   Access To Care Woes   Public Coverage More Efficient   Empowering Consumers

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Keenan, P. S. Articles by Phillips, K. A. Search for Related Content PubMed PubMed Citation Articles by Keenan, P. S. Articles by Phillips, K. A. Related Collections Insurance Market Access To Care Business Of Health Consumer Issues Evidence-Based Medicine Insurance Coverage Managed Care - Medicare Medicare Pharmaceuticals Research And Technology Health Spending

Coverage

Biotechnology And Medicare’s New Technology Policy: Lessons From Three Case Studies

Biotechnology has figured prominently in recent Medicare coverage and payment policies. Biotech treatments push policy boundaries for several reasons: They attract strong patient demand; they often treat rare or life-threatening diseases; they may have uncertain evidence of health benefits; and they are often costly. This paper considers case studies of Medicare coverage for off-label uses of biotech cancer drugs and payments for anemia biopharmaceuticals. The cases suggest Medicare’s ongoing challenge to balance access considerations, the role and strength of evidence, and cost consequences of new treatments.

                      What's this?

This article has been cited by other articles:

				J. Oberlander Through the Looking Glass: The Politics of the Medicare Prescription Drug, Improvement, and Modernization Act Journal of Health Politics Policy and Law, April 1, 2007; 32(2): 187 - 219. [Abstract] [PDF]